Results 71 to 80 of about 3,438 (125)
Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol. [PDF]
Amin S +5 more
europepmc +1 more source
Update on Retinoblastoma Therapies
Retinoblastoma is a success story in pediatric oncology, evolving from life-saving interventions to approaches that preserve eyes and vision while minimizing complications. Initially managed with enucleation and radiotherapy, treatment now emphasizes eye
Cristina A. Martínez Arce +4 more
doaj +1 more source
A 78-year-old man with a history of lung cancer, chemotherapy, radiotherapy, and coronavirus disease 2019 infection experienced visual deterioration of two-weeks’ duration in his right eye.
Mustafa Kayabaşı +8 more
doaj +1 more source
Precision Intravitreal Chemotherapy for Localized Vitreous Seeding of Retinoblastoma. [PDF]
Yu MD, Dalvin LA, Welch RJ, Shields CL.
europepmc +1 more source
Adverse drug reaction after intravitreal injection of topotecan
Subina Narang +4 more
doaj +1 more source
Advancements in Retinoblastoma Treatment: Unraveling the Potential of Intravitreal Chemotherapy. [PDF]
Tanveer S +9 more
europepmc +1 more source
Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience. [PDF]
Dalvin LA +7 more
europepmc +1 more source
Current and Emerging Therapies in Primary Vitreoretinal Lymphoma: A Narrative Review. [PDF]
Cioboată ML +6 more
europepmc +1 more source

